Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes

A. Lladó; P. Mannucci; A. F. Carpentier; S. Paris; Y. Blanco; A. Saiz; J. Y. Delattre; F. Graus

Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes

A. Lladó, P. Mannucci, A. F. Carpentier, S. Paris, Y. Blanco, A. Saiz, J. Y. Delattre, F. Graus

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article › peer-review

Abstract

The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.

Original language	English
Pages (from-to)	1947-1949
Number of pages	3
Journal	Neurology
Volume	63
Issue number	10
Publication status	Published - Nov 23 2004

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

Fingerprint Dive into the research topics of 'Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes'. Together they form a unique fingerprint.

Cite this

@article{b45561e4444a41b586431133300d651e,

title = "Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes",

abstract = "The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.",

author = "A. Llad{\'o} and P. Mannucci and Carpentier, {A. F.} and S. Paris and Y. Blanco and A. Saiz and Delattre, {J. Y.} and F. Graus",

year = "2004",

month = nov,

day = "23",

language = "English",

volume = "63",

pages = "1947--1949",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes

AU - Lladó, A.

AU - Mannucci, P.

AU - Carpentier, A. F.

AU - Paris, S.

AU - Blanco, Y.

AU - Saiz, A.

AU - Delattre, J. Y.

AU - Graus, F.

PY - 2004/11/23

Y1 - 2004/11/23

N2 - The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.

AB - The long-term evolution of Hu antibody (Hu-Ab) titers in patients with paraneoplastic neurologic syndromes (PNSs) is not known. Described is the evolution of Hu-Ab titers in 35 patients with PNS with a median follow-up of 32 months (range 6 to 108 months). No correlation was observed between Hu-Ab titers and neurologic outcome, tumor evolution, or type of treatment. Serial Hu-Ab determinations are not useful for monitoring the clinical outcome of patients with PNS.

UR - http://www.scopus.com/inward/record.url?scp=8844240580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844240580&partnerID=8YFLogxK

M3 - Article

C2 - 15557520

AN - SCOPUS:8844240580

VL - 63

SP - 1947

EP - 1949

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 10

ER -